EX-99.1 2 d123849dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

PRESS RELEASE

INVESTOR CONTACT:

Lisa L. Ewbank

Synopsys, Inc.

650-584-1901

Synopsys-ir@synopsys.com

EDITORIAL CONTACT:

Simone Souza

Synopsys, Inc.

650-584-6454

simone@synopsys.com

Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2021

Q4 FY 2021 Financial Highlights

 

   

Revenue: $1.152 billion

 

   

GAAP earnings per share: $1.28

 

   

Non-GAAP earnings per share: $1.82

FY 2021 Financial Highlights

 

   

Revenue: $4.204 billion

 

   

GAAP earnings per share: $4.81

 

   

Non-GAAP earnings per share: $6.84

 

   

Cash flow from operations: $1.493 billion

 

   

Cash, cash equivalents and short-term investments: $1.581 billion

MOUNTAIN VIEW, Calif. Dec. 1, 2021Synopsys, Inc. (Nasdaq: SNPS) today reported results for its fourth quarter and fiscal year 2021. Revenue for the fourth quarter of fiscal year 2021 was $1.152 billion, compared to $1.025 billion for the fourth quarter of fiscal year 2020. Revenue for fiscal year 2021 was $4.204 billion, an increase of 14.1 percent from $3.685 billion in fiscal year 2020.

“Synopsys delivered another record fiscal year in 2021, substantially exceeding our original targets, with strength in all product groups and geographies. We are entering fiscal year 2022 with significant financial, technology and customer momentum,” said Aart de Geus, chairman and co-CEO of Synopsys. “Over the past several years, we have delivered disruptive innovations that are enabling the new era of ‘smart everything,’ an era that brings with it many new market entrants and increased investments. As a result, we are seeing a growing number of substantially expanded customer commitments and collaborations. In addition to fiscal year 2022 expectations of strong double-digit revenue growth, continued operating margin expansion, EPS growth in the mid-teens range, and nearly $1.5 billion in operating cash flow, we are also raising our long-term financial objectives, with increased EDA and IP revenue growth expectations.”

 

1


GAAP Results

On a generally accepted accounting principles (GAAP) basis, net income for the fourth quarter of fiscal year 2021 was $201.4 million, or $1.28 per share, compared to $197.5 million, or $1.26 per share, for the fourth quarter of fiscal year 2020. GAAP net income for fiscal year 2021 was $757.5 million, or $4.81 per share, compared to $664.3 million, or $4.27 per share, for fiscal year 2020.

Non-GAAP Results

On a non-GAAP basis, net income for the fourth quarter of fiscal year 2021 was $285.8 million, or $1.82 per share, compared to non-GAAP net income of $247.7 million, or $1.58 per share, for the fourth quarter of fiscal year 2020. Non-GAAP net income for fiscal year 2021 was $1.077 billion, or $6.84 per share, compared to non-GAAP net income of $864.6 million, or $5.55 per share, for fiscal year 2020.

For a reconciliation between GAAP and non-GAAP results, see “GAAP to Non-GAAP Reconciliation” in the accompanying tables below.

Business Segments

Synopsys reports revenue and operating income in two segments: (1) Semiconductor & System Design, which includes EDA and IP products, system integration solutions and associated services, and (2) Software Integrity, which includes security and quality solutions for software development. Further information regarding these segments is provided at the end of this press release.

Financial Targets

Synopsys also provided its consolidated financial targets for the first quarter and full fiscal year 2022. These financial targets assume that there are no further changes to the current U.S. government “Entity List” restrictions. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see “Forward-Looking Statements” below.

 

2


First Quarter and Fiscal Year 2022 Financial Targets

(in millions except per share amounts)

 

     Range for Three Months     Range for Fiscal Year  
     January 31, 2022     October 31, 2022  
     Low     High     Low     High  

Revenue

   $ 1,250     $ 1,280     $ 4,725     $ 4,775  

GAAP Expenses

   $ 934     $ 964     $ 3,778     $ 3,835  

Non-GAAP Expenses

   $ 802     $ 812     $ 3,225     $ 3,255  

Other Income (Expense)

   $ (5   $ (3   $ (11   $ (7

Annual non-GAAP Tax Rate

     18     18     18     18

Outstanding Shares (fully diluted)

     156       159       157       160  

GAAP EPS

   $ 1.75     $ 1.92     $ 5.39     $ 5.65  

Non-GAAP EPS

   $ 2.35     $ 2.40     $ 7.73     $ 7.80  

Operating Cash Flow

       $ 1,400     $ 1,500  

Earnings Call Open to Investors

Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys’ corporate website at www.synopsys.com. A recording of the call will be available by calling +1-866-207-1041 (+1-402-970-0847 for international callers), access code 6504511, beginning at 5:45 p.m. Pacific Time today, until 11:59 p.m. Pacific Time on December 8, 2021. A webcast replay will also be available on the corporate website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the first quarter of fiscal year 2022 in February 2022. Synopsys will post copies of the prepared remarks of Aart de Geus, chairman and co-chief executive officer, and Trac Pham, chief financial officer, on its website following today’s call. In addition, Synopsys makes additional information available in a financial supplement and corporate overview presentation, also posted on the corporate website.

Effectiveness of Information

The targets included in this press release, the statements made during the earnings conference call and the information contained in the financial supplement and corporate overview presentation (available in the Investor Relations section of Synopsys’ corporate website at www.synopsys.com) represent Synopsys’ expectations and beliefs as of the date of this release only. Although this press release, copies of the prepared remarks of the co-chief executive

 

3


officer and chief financial officer made during the call, the financial supplement, and the corporate overview presentation will remain available on Synopsys’ website through the date of the first quarter of fiscal year 2022 earnings call in February 2022, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys does not currently intend to report on its progress during the first quarter of fiscal year 2022 or comment to analysts or investors on, or otherwise update, the targets given in this release.

Availability of Final Financial Statements

Synopsys will include final financial statements for fiscal year 2021 in its annual report on Form 10-K to be filed by December 29, 2021.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Software partner for innovative companies developing the electronic products and software applications we rely on every day. As an S&P 500 company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and offers the industry’s broadest portfolio of application security testing tools and services. Whether you’re a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing more secure, high-quality code, Synopsys has the solutions needed to deliver innovative products. Learn more at www.synopsys.com.

GAAP to Non-GAAP Reconciliation

Synopsys continues to provide all information required in accordance with GAAP but believes evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys’ operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal planning and forecasting purposes. Synopsys’ management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Synopsys’ management believes it is useful for itself and investors to review, as applicable, both GAAP information that

 

4


includes: (i) the amortization of acquired intangible assets, (ii) the impact of stock compensation, (iii) acquisition-related costs, (iv) restructuring charges, (v) the effects of certain settlements, final judgments and loss contingencies related to legal proceedings, and (vi) the income tax effect of non-GAAP pre-tax adjustments; and the non-GAAP measures that exclude such information in order to assess the performance of Synopsys’ business and for planning and forecasting in subsequent periods.

Synopsys adopted a three-year normalized non-GAAP tax rate of 16% for fiscal year 2019 through 2021 in the calculation of its non-GAAP financial measures to provide better consistency across interim reporting periods by eliminating the effects of non-recurring and period-specific items, which can vary in size and frequency and not necessarily reflect our normal operations, and to align our tax rate more clearly with our expected geographic earnings mix. Synopsys re-evaluated this rate on an annual basis for any significant events that could have materially affected its projections, such as significant changes in its geographic earnings mix or significant tax law changes in major jurisdictions where it operates.

Given the uncertainty surrounding corporate tax reform, Synopsys has elected to provide a projected annual non-GAAP tax rate for fiscal year 2022 rather than a three-year normalized non-GAAP tax rate in calculating its non-GAAP financial measures. Based on an evaluation of Synopsys’ historical and projected mix of U.S. and international profit before tax, taking into account the impact of non-GAAP adjustments described above, as well as other factors such as its current tax structure, existing tax positions, and expected recurring tax incentives, its projected annual non-GAAP tax rate is 18% for fiscal 2022. Synopsys intends to re-evaluate the projected fiscal 2022 annual non-GAAP tax rate on an interim basis to determine the appropriateness of adopting a multi-year normalized non-GAAP tax rate.

Whenever Synopsys uses a non-GAAP financial measure, it provides a reconciliation of the non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed below, as well as Item 2.02 of the Current Report on Form 8-K filed on December 1, 2021 for additional information about the measures Synopsys uses to evaluate its core business operations.

 

5


Reconciliation of Fourth Quarter and Fiscal Year 2021 Results

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income and earnings per share for the periods indicated below.

GAAP to Non-GAAP Reconciliation of Fourth Quarter and Fiscal Year 2021 Results (1)

(unaudited and in thousands, except per share amounts)

 

     Three Months Ended      Twelve Months Ended  
     October 31,      October 31,  
     2021      2020      2021      2020  

GAAP net income

   $  201,447      $ 197,455      $ 757,516      $ 664,347  

Adjustments:

           

Amortization of intangible assets

     21,943        21,004        82,380        91,281  

Stock compensation

     96,742        78,429        345,272        248,584  

Acquisition-related costs

     3,800        3,259        15,394        14,096  

Restructuring charges

     18,254        (387      33,405        36,059  

Legal matters

     —          —          (1,455      —    

Tax adjustments

     (56,430      (52,084      (155,727      (189,798
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP net income

   $ 285,756      $ 247,676      $ 1,076,785      $ 864,569  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Three Months Ended      Twelve Months Ended  
     October 31,      October 31,  
     2021      2020      2021      2020  

GAAP diluted net income per share

   $ 1.28      $ 1.26      $ 4.81      $ 4.27  

Adjustments:

           

Amortization of intangible assets

     0.14        0.13        0.52        0.59  

Stock compensation

     0.62        0.50        2.19        1.60  

Acquisition-related costs

     0.02        0.02        0.10        0.08  

Restructuring charges

     0.12        —          0.21        0.23  

Legal matters

     —          —          (0.01      —    

Tax adjustments

     (0.36      (0.33      (0.98      (1.22
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP diluted net income per share

   $ 1.82      $ 1.58      $ 6.84      $ 5.55  
  

 

 

    

 

 

    

 

 

    

 

 

 

Shares used in computing diluted net income per share amounts

     157,243        156,825        157,340        155,706  

 

(1)

Synopsys’ fourth quarter of fiscal year 2021 and 2020 ended on October 30, 2021 and October 31, 2020, respectively. For presentation purposes, we refer to the closest calendar month end.

Reconciliation of 2022 Targets

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

 

6


GAAP to Non-GAAP Reconciliation of First Quarter Fiscal Year 2022 Targets (1)

(in thousands, except per share amounts)

 

     Range for Three Months  
     January 31, 2022  
     Low      High  

Target GAAP expenses

   $ 934,000      $ 964,000  

Adjustments:

     

Amortization of intangible assets

     (22,000      (25,000

Stock compensation

     (102,000      (107,000

Restructuring charges

     (8,000      (20,000
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 802,000      $ 812,000  
  

 

 

    

 

 

 
     Range for Three Months  
     January 31, 2022  
     Low      High  

Target GAAP earnings per share

   $ 1.75      $ 1.92  

Adjustments:

     

Amortization of intangible assets

     0.16        0.14  

Stock compensation

     0.68        0.65  

Restructuring charges

     0.13        0.05  

Tax adjustments

     (0.37      (0.36
  

 

 

    

 

 

 

Target non-GAAP earnings per share

   $ 2.35      $ 2.40  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     157,500        157,500  

 

7


GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2022 Targets (1)

(in thousands, except per share amounts)

 

                                           
     Range for Fiscal Year  
     October 31, 2022  
     Low      High  

Target GAAP expenses

   $ 3,778,000      $ 3,835,000  

Adjustments:

     

Amortization of intangible assets

     (80,000      (85,000

Stock compensation

     (465,000      (475,000

Restructuring charges

     (8,000      (20,000
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 3,225,000      $ 3,255,000  
  

 

 

    

 

 

 

 

                                       
     Range for Fiscal Year  
     October 31, 2022  
     Low      High  

Target GAAP earnings per share

   $ 5.39      $ 5.65  

Adjustments:

     

Amortization of intangible assets

     0.54        0.50  

Stock compensation

     3.00        2.93  

Restructuring charges

     0.13        0.05  

Tax adjustments

     (1.33      (1.33
  

 

 

    

 

 

 

Target non-GAAP earnings per share

   $ 7.73      $ 7.80  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     158,500        158,500  

 

(1)

Synopsys’ first fiscal quarter and fiscal year will end on January 29, 2022 and October 29, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

Forward-Looking Statements

This press release contains forward-looking statements including, but not limited to, statements regarding Synopsys’ short-term and long-term financial targets, expectations and objectives; business outlook, opportunities and strategies; customer demand and market expansion; strategies related to our products and technology; our planned product releases and capabilities; industry growth rates; software trends; planned acquisitions and buybacks; our expected tax rate; the expected impact of U.S. and foreign government action on our financial results; and the continued impact and duration of the COVID-19 pandemic. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in our forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks from the continued impact of the COVID-19 pandemic on the global economy and on our business, operations and financial condition; uncertainty in the growth of the semiconductor and electronics industries; macroeconomic conditions and uncertainty in the global economy; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations as well as actions by the

 

8


U.S. or foreign governments, such as measures in response to the COVID-19 pandemic or the imposition of additional tariffs or export restrictions; fluctuation of our operating results; and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys’ results is included in filings it makes with the Securities and Exchange Commission from time to time, including in the sections entitled “Risk Factors” in its Annual Report on Form 10-K for the fiscal year ended October 31, 2020 and in its latest Quarterly Report on Form 10-Q. The information provided herein is as of December 1, 2021. Synopsys undertakes no duty, and does not intend to update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

###

 

9


SYNOPSYS, INC.

Unaudited Consolidated Statements of Operations (1)

(in thousands, except per share amounts)

 

     Three Months Ended     Twelve Months Ended  
     October 31,     October 31,  
     2021     2020     2021     2020  

Revenue:

        

Time-based products

   $ 688,116     $ 606,598     $ 2,633,763     $ 2,365,199  

Upfront products

     274,265       244,155       861,063       735,572  

Maintenance and service

     190,038       174,686       709,367       584,510  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenue

     1,152,419       1,025,439       4,204,193       3,685,281  

Cost of revenue:

        

Products

     152,437       142,838       542,114       487,307  

Maintenance and service

     68,992       69,991       271,202       254,931  

Amortization of intangible assets

     13,297       11,720       48,461       52,452  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenue

     234,726       224,549       861,777       794,690  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     917,693       800,890       3,342,416       2,890,591  

Operating expenses:

        

Research and development

     413,864       339,566       1,504,823       1,279,022  

Sales and marketing

     197,681       176,499       712,491       632,010  

General and administrative

     88,960       79,796       322,988       284,530  

Amortization of intangible assets

     8,646       9,284       33,919       38,829  

Restructuring charges

     18,254       (387     33,405       36,059  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     727,405       604,758       2,607,626       2,270,450  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     190,288       196,132       734,790       620,141  

Other income (expense), net

     8,790       (4,095     70,724       18,018  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     199,078       192,037       805,514       638,159  

Provision (benefit) for income taxes

     (2,059     (4,989     49,155       (25,288
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     201,137       197,026       756,359       663,447  

Net income (loss) attributed to non-controlling interest

     (310     (429     (1,157     (900
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributed to Synopsys

   $ 201,447     $ 197,455     $ 757,516     $ 664,347  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share:

        

Basic

   $ 1.32     $ 1.30     $ 4.96     $ 4.40  

Diluted

   $ 1.28     $ 1.26     $ 4.81     $ 4.27  

Shares used in computing per share amounts:

        

Basic

     152,932       152,349       152,698       151,135  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

     157,243       156,825       157,340       155,706  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

Synopsys’ fourth quarter of fiscal year 2021 and 2020 ended on October 30, 2021 and October 31, 2020, respectively. For presentation purposes, we refer to the closest calendar month end.

 

10


SYNOPSYS, INC.

Unaudited Consolidated Balance Sheets (1)

(in thousands, except par value amounts)

 

     October 31, 2021     October 31, 2020  

ASSETS:

    

Current assets:

    

Cash and cash equivalents

   $ 1,432,840     $ 1,235,653  

Short-term investments

     147,949       —    
  

 

 

   

 

 

 

Total cash, cash equivalents & short-term investments

   $ 1,580,789     $ 1,235,653  

Accounts receivable, net

     568,501       780,709  

Inventories, net

     229,023       192,333  

Income taxes receivable and prepaid taxes

     32,411       32,355  

Prepaid and other current assets

     397,617       308,167  
  

 

 

   

 

 

 

Total current assets

     2,808,341       2,549,217  

Property and equipment, net

     472,398       483,818  

Operating lease right-of-use assets, net

     493,251       465,818  

Goodwill

     3,575,785       3,365,114  

Intangible assets, net

     279,132       254,322  

Deferred income taxes

     612,655       497,546  

Other long-term assets

     510,698       414,227  
  

 

 

   

 

 

 

Total assets

   $ 8,752,260     $ 8,030,062  
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY:

    

Current liabilities:

    

Accounts payable and accrued liabilities

   $ 694,748     $ 623,664  

Operating lease liabilities, current

     79,678       73,173  

Accrued income taxes

     46,443       27,738  

Deferred revenue

     1,517,623       1,388,263  

Short-term debt

     74,992       27,084  
  

 

 

   

 

 

 

Total current liabilities

     2,413,484       2,139,922  

Operating lease liabilities, non-current

     487,003       462,411  

Long-term accrued income taxes

     27,893       25,178  

Long-term deferred revenue

     136,303       104,850  

Long-term debt

     25,094       100,823  

Other long-term liabilities

     363,540       284,511  
  

 

 

   

 

 

 

Total liabilities

     3,453,317       3,117,695  

Stockholders’ equity:

    

Preferred stock, $ 0.01 par value: 2,000 shares authorized; none outstanding

     —         —    

Common stock, $ 0.01 par value: 400,000 shares authorized; 153,062 and 152,618 shares outstanding, respectively

     1,531       1,528  

Capital in excess of par value

     1,576,363       1,653,166  

Retained earnings

     4,549,713       3,795,397  

Treasury stock, at cost: 4,198 and 4,643 shares, respectively

     (782,866     (488,613

Accumulated other comprehensive income (loss)

     (49,604     (54,074
  

 

 

   

 

 

 

Total Synopsys stockholders’ equity

     5,295,137       4,907,404  

Non-controlling interest

     3,806       4,963  
  

 

 

   

 

 

 

Total stockholders’ equity

     5,298,943       4,912,367  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 8,752,260     $ 8,030,062  
  

 

 

   

 

 

 

 

(1)

Synopsys’ fiscal year 2021 and 2020 ended on October 30, 2021 and October 31, 2020, respectively. For presentation purposes, we refer to the closest calendar month end.

 

11


SYNOPSYS, INC.

Unaudited Consolidated Statements of Cash Flows (1)

(in thousands)

 

     Twelve Months Ended
October 31,
 
     2021     2020  

CASH FLOWS FROM OPERATING ACTIVITIES:

    

Net income attributed to Synopsys

   $ 757,516     $ 664,347  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Amortization and depreciation

     203,676       209,986  

Reduction of operating lease right-of-use assets

     86,645       82,895  

Amortization of capitalized costs to obtain revenue contracts

     64,698       61,185  

Stock-based compensation

     345,272       248,584  

Allowance for doubtful accounts

     18,515       20,875  

Deferred income taxes

     (128,583     (111,526

Other non-cash

     14,702       3,425  

Net changes in operating assets and liabilities, net of acquired assets and liabilities:

    

Accounts receivable

     201,706       (236,806

Inventories

     (48,046     (55,024

Prepaid and other current assets

     (102,174     (11,298

Other long-term assets

     (153,037     (83,367

Accounts payable and accrued liabilities

     125,133       113,773  

Operating lease liabilities

     (82,581     (78,578

Income taxes

     28,855       14,120  

Deferred revenue

     160,325       148,722  
  

 

 

   

 

 

 

Net cash provided by operating activities

     1,492,622       991,313  

CASH FLOWS FROM INVESTING ACTIVITIES:

    

Proceeds from sales and maturities of short-term investments

     12,850       —    

Purchases of short-term investments

     (161,732     —    

Proceeds from sales of long-term investments

     —         2,151  

Purchases of long-term investments

     (7,591     (2,762

Purchases of property and equipment

     (93,764     (154,717

Cash paid for acquisitions, net of cash acquired

     (296,017     (201,045

Capitalization of software development costs

     (1,976     (4,045

Other

     (800     —    
  

 

 

   

 

 

 

Net cash used in investing activities

     (549,030     (360,418

CASH FLOWS FROM FINANCING ACTIVITIES:

    

Proceeds from credit facilities

     —         276,489  

Repayment of debt

     (28,061     (288,879

Issuances of common stock

     210,719       197,403  

Payments for taxes related to net share settlement of equity awards

     (138,950     (82,225

Purchase of equity forward contract

     (35,000     —    

Purchases of treasury stock

     (753,081     (242,078

Other

     (4,375     (1,316
  

 

 

   

 

 

 

Net cash used in financing activities

     (748,748     (140,606

Effect of exchange rate changes on cash, cash equivalents and restricted cash

     2,369       17,154  
  

 

 

   

 

 

 

Net change in cash, cash equivalents and restricted cash

     197,213       507,443  

Cash, cash equivalents and restricted cash, beginning of year

     1,237,970       730,527  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash, end of period

   $  1,435,183     $ 1,237,970  
  

 

 

   

 

 

 

 

(1)

Synopsys’ fiscal year 2021 and 2020 ended on October 30, 2021 and October 31, 2020, respectively. For presentation purposes, we refer to the closest calendar month end.

 

12


SYNOPSYS, INC.

Business Segment Reporting (1)

(in millions)

 

     Three Months     Three Months     Twelve Months     Twelve Months  
     Ended     Ended     Ended     Ended  
     October 31, 2021 (3)     October 31, 2020 (3)     October 31, 2021 (3)     October 31, 2020 (3)  

Revenue by segment

        

- Semiconductor & System Design

   $ 1,042.4     $ 934.6     $ 3,810.4     $ 3,327.2  

% of Total

     90.5     91.1     90.6     90.3

- Software Integrity

   $ 110.0     $ 90.8     $ 393.8     $ 358.1  

% of Total

     9.5     8.9     9.4     9.7

Total segment revenue

   $ 1,152.4     $ 1,025.4     $ 4,204.2     $ 3,685.3  

Adjusted operating income by segment

        

- Semiconductor & System Design

   $ 326.6     $ 293.5     $ 1,243.1     $ 990.8  

- Software Integrity

   $ 13.3     $ 6.2     $ 38.3     $ 40.8  

Total adjusted segment operating income

   $ 339.9     $ 299.7     $ 1,281.4     $ 1,031.6  

Adjusted operating margin by segment

        

- Semiconductor & System Design

     31.3     31.4     32.6     29.8

- Software Integrity

     12.1     6.8     9.7     11.4

Total adjusted segment operating margin

     29.5     29.2     30.5     28.0

Total Adjusted Segment Operating Income Reconciliation (1)(2)

(in millions)

 

     Three Months      Three Months     Twelve Months     Twelve Months  
     Ended      Ended     Ended     Ended  
     October 31, 2021 (3)      October 31, 2020 (3)     October 31, 2021 (3)     October 31, 2020 (3)  

GAAP total operating income – as reported

   $ 190.3      $ 196.1     $ 734.8     $ 620.1  

Other expenses managed at consolidated level

         

-Amortization of intangible assets

     21.9        21.0       82.4       91.3  

-Stock compensation

     96.7        78.4       345.3       248.6  

-Non-qualified deferred compensation plan

     8.9        1.3       71.6       21.5  

-Acquisition-related costs

     3.8        3.3       15.4       14.1  

-Restructuring

     18.3        (0.4     33.4       36.1  

-Legal matters

     —          —         (1.5     —    
  

 

 

    

 

 

   

 

 

   

 

 

 

Total adjusted segment operating income

   $ 339.9      $ 299.7     $ 1,281.4     $ 1,031.6  
  

 

 

    

 

 

   

 

 

   

 

 

 

 

(1)

Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of revenue and profitability as normal elements of our business. Amounts may not foot due to rounding.

(2)

These segment results are consistent with the information required by ASC 280, Segment Reporting. They are presented to reflect the information that is considered by Synopsys’ chief operating decision makers (CODMs) to evaluate the operating performance of its segments. The CODMs do not allocate certain operating expenses managed at a consolidated level to our reportable segments, and as a result, the reported operating income and operating margin do not include these unallocated expenses as shown in the table above. Amounts may not foot due to rounding.

(3)

Synopsys’ fourth quarter of fiscal year 2021 and 2020 ended on October 30, 2021 and October 31, 2020, respectively. For presentation purposes, we refer to the closest calendar month end.

 

13